Advertisement
How rates of colectomy and biologics use have changed over time
Post hoc analysis of phase 3 trial shows benefit
Risk reduction guidelines
Removing malignancy while maintaining breast appearance
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
IMbrave-150 changes standard of care
On the purpose, process and results
Two-drug therapy reduces progression in rare hereditary cancer syndrome
Leader plans to collaborate with other medical disciplines for the benefits of patients with obesity.
Bridge to transplant after acetaminophen overdose
Mitigating the risk requires physicians to take an active role in the care of patients with obesity
Advertisement
Advertisement